Current:Home > MarketsFederal judge blocks some rules on abortion pills in North Carolina -FutureWise Finance
Federal judge blocks some rules on abortion pills in North Carolina
View
Date:2025-04-18 16:21:22
RALEIGH, N.C. (AP) — A federal judge has permanently blocked some efforts in North Carolina to restrict how abortion pills can be dispensed, saying they are unlawfully in conflict with the authority of the U.S. Food and Drug Administration. But she allowed other state laws to remain in effect, granting only a partial victory to a doctor who sued.
The injunction entered Monday by U.S. District Judge Catherine Eagles in Greensboro gives permanence to her April 30 ruling that some of North Carolina’s regulations on medication abortion have been preempted by decisions of federal drug regulators that determined they were not needed.
The order Monday means North Carolina cannot require that only doctors prescribe the pills; that the drugs be provided to the patient only in person; and that the patient schedule a follow-up appointment. It also prohibits state and local prosecutors, state health and medical officials and other defendants from enforcing such rules or penalizing people who don’t follow them with criminal, civil and professional penalties.
Congress delegated authority to the FDA to scrutinize the use of mifepristone, which the agency approved in 2000 to end pregnancy when used in combination with a second drug, misoprostol. The FDA expressly determined that restrictions similar to North Carolina’s were no longer necessary, based on evaluations of their safe distribution and use, Eagles wrote in April.
Her order means patients in North Carolina apparently can now receive the pills through pharmacies — prescribed through a health care practitioner other than a doctor — and take them at home, in keeping with FDA decisions.
But Eagles also upheld some challenged restrictions, such as requiring an in-person consultation 72 hours in advance, an in-person examination and an ultrasound before obtaining a prescription. She said these rules had either not been expressly reviewed and rejected by the FDA, or focus more on the practice of medicine or on general patient health.
Dr. Amy Bryant, who provides abortions and raised this legal challenge last year, said in a prepared statement that the permanent injunction will “allow for increased access to safe and effective medication abortion care throughout North Carolina.”
The challenged regulations on medication abortion are in a 2023 law enacted by the Republican-controlled General Assembly that carried onward or expanded many previous abortion restrictions. One change reduced the time frame for most abortions from after 20 weeks of pregnancy to 12 weeks.
Tami Fitzgerald, executive director of the conservative North Carolina Values Coalition, said Tuesday that the ruling “lowers the standard of care for women.” She also criticized the order for stopping a state requirement that “non-fatal adverse events” related to mifepristone be reported to the FDA, saying it would conceal “dangerous complications and side effects of abortion drugs.”
Democratic Attorney General Josh Stein, an abortion rights supporter now running for governor, didn’t defend the restrictions in court because he already contended they were preempted by the FDA’s decisions. He blamed Republican lawmakers on Tuesday for the unlawful provisions and said, “this ruling helps women regain some control over their personal health care decisions.”
The offices of House Speaker Tim Moore and Senate leader Phil Berger, who joined the case to defend the laws, didn’t immediately respond Tuesday to an email seeking comment. They could appeal Eagles’ order. A ruling could come soon in a separate case at the U.S. Supreme Court brought by anti-abortion doctors who want the justices to restrict access to mifepristone.
veryGood! (85941)
Related
- Whoopi Goldberg is delightfully vile as Miss Hannigan in ‘Annie’ stage return
- ‘Gran Turismo’ takes weekend box office crown over ‘Barbie’ after all
- Fire rescue helicopter crashes into building in Florida; 2 dead, 2 hospitalized
- Benches clear twice in an inning as Rays hand Yankees another series defeat
- South Korea's acting president moves to reassure allies, calm markets after Yoon impeachment
- Even in the most depressed county in America, stigma around mental illness persists
- Alabama presses effort to execute inmate by having him breathe pure nitrogen. And the inmate agrees.
- House Republicans move closer to impeachment inquiry
- Moving abroad can be expensive: These 5 countries will 'pay' you to move there
- MSG Sphere announces plan to power 70% of Las Vegas arena with renewable energy, pending approval
Ranking
- Krispy Kreme offers a free dozen Grinch green doughnuts: When to get the deal
- China won’t require COVID-19 tests for incoming travelers in a milestone in its reopening
- Illinois judge refuses to dismiss case against father of parade shooting suspect
- Why you can’t get ‘Planet of the Bass,’ the playful ‘90s Eurodance parody, out of your head
- NFL Week 15 picks straight up and against spread: Bills, Lions put No. 1 seed hopes on line
- Why you can’t get ‘Planet of the Bass,’ the playful ‘90s Eurodance parody, out of your head
- Jessie James Decker Shares Pregnancy Reaction After Husband Eric's Vasectomy Didn't Happen
- After Supreme Court curtails federal power, Biden administration weakens water protections
Recommendation
Taylor Swift makes surprise visit to Kansas City children’s hospital
'Frightening and shocking': Some Black Americans fear violence after Jacksonville Dollar General shooting
Collaborative effort helps US men's basketball cruise past Greece, into World Cup second round
UNC faculty member killed in campus shooting and a suspect is in custody, police say
Senate begins final push to expand Social Security benefits for millions of people
Denver to pay $4.7 million to settle claims it targeted George Floyd protesters for violating curfew
Judge sets March 2024 trial date in Trump's federal case related to 2020 election
Student loan repayments are set to resume. Here's what to know.